Ronney Abaza, MD
Urology · Worthington, OHNPI 1134173339
Payments from drug & device makers
Across 387 payments — averaging $1030.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vascular Technology, Inc.$150K
- Intuitive Surgical$126K
- Conmed Corporation$90K
- Medtronic$24K
- Johnson & Johnson$3K
- Urogen Pharma, Inc.$732
- plus $5K from 31 others
Across 4 payments — averaging $31,250 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Conmed Corporation$125K
What the payments were for
- Consulting fees$93,02525%
- Speaking & faculty fees$202,77554%
- Travel & lodging$7,3292%
- Food & beverage$17,3985%
- Education$53,45014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vascular Technology, Inc. | 7 | $149,900 |
| Intuitive Surgical | 147 | $126,324 |
| Conmed Corporation | 54 | $89,804 |
| Medtronic | 33 | $23,837 |
| Johnson & Johnson(3 entities) | 12 | $3,350 |
| Urogen Pharma, Inc. | 16 | $732 |
| Ferring Pharmaceuticals Inc. | 7 | $613 |
| Progenics Pharmaceuticals, Inc. | 7 | $440 |
| Sumitomo Pharma America, Inc. | 17 | $380 |
| Merck | 12 | $369 |
| Histosonics, Inc. | 2 | $302 |
| Immunitybio, Inc. | 3 | $242 |
| Amgen | 9 | $225 |
| Vertex | 4 | $185 |
| Angiodynamics, Inc. | 2 | $170 |
| Procept Biorobotics Corporation | 2 | $162 |
| Astellas Pharma US Inc | 4 | $162 |
| Endo Pharmaceuticals Inc. | 2 | $161 |
| Telix Pharmaceuticals | 1 | $158 |
| Olympus America Inc. | 2 | $152 |
| Endo USA, Inc. | 2 | $147 |
| Myovant Sciences Inc. | 7 | $143 |
| E.r. Squibb & Sons, L.L.C. | 7 | $130 |
| Blue Earth Diagnostics | 2 | $129 |
| Corcept Therapeutics | 1 | $125 |
| Tolmar Pharmaceuticals, Inc. | 4 | $112 |
| Myriad Genetic Laboratories, Inc. | 6 | $108 |
| Novartis | 1 | $97 |
| Dendreon Pharmaceuticals LLC | 2 | $79 |
| Laborie Medical Technologies Corp. | 3 | $47 |
| AbbVie | 2 | $46 |
| Urovant Sciences Inc | 2 | $38 |
| Sanofi | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Mimedx Group, Inc. | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$117,791
- AIRSEAL$64,188
- DA VINCI SP$6,450
- CERTUS 140 MICROWAVE ABLATION SYSTEM$800
- ADSTILADRIN$479
- JELMYTO$461
- CONMED SPECIMEN RETRIEVAL$393
- ILLUCCIX$316
- PYLARIFY$309
- XIAFLEX$275
- ANKTIVA$173
- Nanoknife$152
- AquaBeam Robotic System$145
- iTIND System$135
- INTERSTIM$133
- V-LOC 180$126
- Korlym$125
- JOURNAVX$121
- POSLUMA$113
- KEYTRUDA$110
How this compares
$398,977 in reported general payments places this provider in the 95th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 181 | $770 |
| Tamsulosin Hcl | 28 | $224 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $185 |
| Tramadol Hcl | 214 | $167 |
| Finasteride | 11 | $76 |
Paid to pharmacies, not to this prescriber.
Other urology in Worthington
- Marc PliskinCincinnati$20.8M
- Lawrence GervasiMiddleburg Heights$4.7M
- Martin FritzhandCincinnati$4.6M
- Kamal PoharCincinnati$3.4M
- Eric SingerColumbus$2.1M
- Benjamin MartinGahanna$1.1M
- Howard GoldmanCleveland$747K
- Jihad KaoukCleveland$696K
- Raymond RackleyCleveland$695K
- Sandip VasavadaCleveland$512K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.